Key result
Increasing perioperative NT-proBNP is linked to ~133% greater adverse event risk after pediatric CHD surgery.
Why the study?
The association between perioperative changes in NT-proBNP and short-term outcomes in children undergoing surgery for congenital heart disease was unclear.
Is the pattern of change in perioperative NT-proBNP associated with short-term adverse events in children undergoing surgery for congenital heart disease?
Cohort (n=873)
Is the pattern of change in perioperative NT-proBNP associated with short-term adverse events in children undergoing surgery for congenital heart disease?
Hazard Ratio: 2.33 (95% CI 1.52–3.6)
An increasing pattern of perioperative NT-proBNP is strongly associated with short-term postoperative adverse events in children undergoing surgery for congenital heart disease.
OBJECTIVES: This study aimed to determine whether changes in perioperative N-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with short-term outcomes in children undergoing surgery for congenital heart disease (CHD). METHODS: We retrospectively included 873 consecutive children with CHD after cardiac surgery. NT-proBNP concentrations were collected from each child prior to and at 1, 12, 36 and 72 h after surgery. The patients had postsurgical follow-ups at 30, 90 and 180 days. The end point was postoperative composite adverse events. RESULTS: The patients were classified into 3 groups using joint latent class mixture time-to-event models: (i) relatively stable (86.7%), (ii) decreasing (7.2%) and (iii) increasing (6.1%). In total, 257 (29.4%) adverse events occurred. The joint latent class mixture time-to-event models showed that increasing NT-proBNP was strongly associated with adverse events, with adjusted hazard ratio of 2.33 (95% confidence interval 1.52-3.60). Multinomial logistic regression showed that the variables associated with the pattern of change were age, weight at surgery, mode of delivery and cardiopulmonary bypass time. CONCLUSIONS: The pattern of dynamic postsurgical changes in NT-proBNP may facilitate outcome stratification and identification of a high risk for adverse events.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2020) conducted a cohort in congenital heart disease (n=873). Increasing pattern of NT-proBNP vs. Relatively stable or decreasing NT-proBNP patterns was evaluated on postoperative composite adverse events (HR 2.33, 95% CI 1.52-3.60). An increasing pattern of perioperative NT-proBNP was strongly associated with postoperative adverse events in children undergoing congenital heart disease surgery (HR 2.33; 95% CI 1.52-3.60).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: